A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients - Preliminary results

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1074-1075

  Machado, P G P ^a   Garcia, C ^a   Felipe, C R ^a   Garcia, R ^a   Franco, M ^a   Delcelo, R ^a   Silva Jr , H T ^a   Medina, J O P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE; RAPAMYCIN;

CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HAPLOTYPE; HUMAN; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE DISEASE; AZATHIOPRINE; CYCLOSPORINE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PREDNISONE; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 0035077385     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02421-0     Document Type: Conference Paper

References (5)

1. Kahan BD, Julian BA, Pescovitz MD, et al: Transplantation 68:1526, 1999
2. Groth CG, Backman L, Morales JM, et al: Transplantation 67:1036, 1999
3. Kreis H, Cisterne JM, Land L, et al: Transplantation 69:1252, 2000
4. MacDonald A: Transplantation 67(Suppl 9):S546, 1999
5. Kahan BD: Lancet 356:194, 2000